N Komeshima

465 total citations
15 papers, 354 citations indexed

About

N Komeshima is a scholar working on Organic Chemistry, Molecular Biology and Spectroscopy. According to data from OpenAlex, N Komeshima has authored 15 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 8 papers in Molecular Biology and 5 papers in Spectroscopy. Recurrent topics in N Komeshima's work include Cancer therapeutics and mechanisms (5 papers), Asymmetric Synthesis and Catalysis (3 papers) and Microbial Natural Products and Biosynthesis (3 papers). N Komeshima is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Asymmetric Synthesis and Catalysis (3 papers) and Microbial Natural Products and Biosynthesis (3 papers). N Komeshima collaborates with scholars based in Japan. N Komeshima's co-authors include Shunichi Hashimoto, Kenji Koga, Masahiko Watanabe, T Tsuruo, Kiyoshi Tomioka, T Tsuruo, Yoichi Hayakawa, NOBORU OTAKE, Takashi Tsuruo and Shun‐ichi Yamada and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and The Journal of Antibiotics.

In The Last Decade

N Komeshima

15 papers receiving 338 citations

Peers

N Komeshima
Comparison fields: 5 of 53
  • Organic Chemistry 222
  • Molecular Biology 150
  • Oncology 71
  • Spectroscopy 51
  • Pharmacology 43
Bernard Portevin France
J.K.Y. Wong United States
Peter Raddatz Germany
Martin S. Domalski United States
Sergio De Munari Italy
Kenneth Crawford United States
Carl Berthelette Canada
Alan J. Foubister United Kingdom
Yoshikazu Oka Japan
Shung Wu United States
Bernard Portevin France View profile →
Citations per field, relative to N Komeshima
N Komeshima · 1×
Citations per year, relative to N Komeshima
N Komeshima · 1×

Countries citing papers authored by N Komeshima

Since Specialization
Citations

This map shows the geographic impact of N Komeshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Komeshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Komeshima more than expected).

Fields of papers citing papers by N Komeshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Komeshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Komeshima. The network helps show where N Komeshima may publish in the future.

Co-authorship network of co-authors of N Komeshima

This figure shows the co-authorship network connecting the top 25 collaborators of N Komeshima. A scholar is included among the top collaborators of N Komeshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Komeshima. N Komeshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
# Title Journal Authors Indexed citations
1 Synthesis and antitumor activity of 4'-O-acylanthracyclines. The Journal of Antibiotics Hiroyuki Kawai, N Komeshima et al. 1
2 Synthesis and Anti-inflammatory Activity of Antioxidants, 4-Alkylthio-o-anisidine Derivatives. Chemical and Pharmaceutical Bulletin N Komeshima, T. Osawa et al. 7
3 Stereoselective reactions. XVII. Absolute structure-cytotoxic activity relationships of steganacin congeners and analogs Journal of Medicinal Chemistry Kiyoshi Tomioka, Taro Ishiguro et al. 38
4 Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells. PubMed Masahiko Watanabe, N Komeshima et al. 32
5 Role of DNA-binding in the cytotoxicity of an anthracycline, R20X2 and its morpholino analog, MX2. The Journal of Antibiotics N Komeshima, Masahiko Watanabe et al. 5
6 [Effect of MX-2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumors in rats]. PubMed Shuichi Izumoto, Norio Arita et al. 1
7 Antitumor activity of new morpholino anthracyclines. The Journal of Antibiotics N Komeshima, Takashi Tsuruo et al. 18
8 MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells. PubMed Masahiko Watanabe, N Komeshima et al. 47
9 New antitumor antibotics, anguinomycins A and B. The Journal of Antibiotics Yoichi Hayakawa, N Komeshima et al. 25
10 Arugomycin, a new anthracycline antibiotic. III. Biological activities of arugomycin and its analogues obtained by chemical degradation and modification. The Journal of Antibiotics Akihiro Shimosaka, Hiroyuki Kawai et al. 6
11 Stereochemical aspects of asymmetric diels-alder reaction catalyzed by chiral alkoxyaluminum dichlorides Tetrahedron Letters Hiroyuki Takemura, N Komeshima et al. 38
12 A proposed method for exploring anti-aggregatory effects of eicosapentaenoic acid in the rat Prostaglandins Leukotrienes and Medicine Ikuo Morita, N Komeshima et al. 14
13 Asymmetric Diels–Alder reaction catalysed by chiral alkoxyaluminium dichloride Journal of the Chemical Society Chemical Communications Shunichi Hashimoto, N Komeshima et al. 93
14 Stereoselective reactions. II. Asymmetric synthesis of .BETA.-substituted aldehydes by michael reaction using chiral .ALPHA.,.BETA.-unsaturated aldimines. Chemical and Pharmaceutical Bulletin Shunichi Hashimoto, N Komeshima et al. 16
15 Asymmetric michael reaction via chiral α,β-unsaturated aldimines Tetrahedron Letters Shunichi Hashimoto, N Komeshima et al. 13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026